Medical News

RSS

Merck, MD Anderson form strategic clinical research collaboration to evaluate anti-PD-1 therapy

Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines.

14 Aug 2015

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.

13 Aug 2015

Nutrastar's net revenue increases 1.8% to $13.24 million in second quarter 2015

Nutrastar International Inc., a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its results for the three months and six months ended June 30, 2015.

13 Aug 2015

Rhythm Metabolic completes $40 million Series A financing

Rhythm announced today the completion of a $40 million Series A financing for its subsidiary, Rhythm Metabolic, Inc., which is developing setmelanotide (RM-493), a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies in the MC4 pathway.

13 Aug 2015

Health Gorilla announces launch of expanded physician portal

Health Gorilla today announced the launch of its expanded physician portal, part of a new clinical network the company will unveil next month to connect doctors, vendors, and patients within a single, secure platform.

13 Aug 2015

CPhI reports positive outlook on the Chinese pharmaceutical market

CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.

13 Aug 2015

New endoscopic system differentiates between malignant and benign tumors in gastrointestinal tract

Cancer or no cancer? This question can usually only be answered after a days-long wait for a histological examination. With the use of a mass spectrometric technique, the answer may soon be available in real time.

13 Aug 2015

RealTime Dynamix: New monthly service launched for pharmaceutical markets

Spherix Global Insights announces the launch of RealTime Dynamix, its new monthly service developed to keep clients on the pulse in highly dynamic specialty markets.

13 Aug 2015

Charlotte charity Taylor's Tale inspires new law to create treatments for rare diseases, spur growth in NC

Charlotte charity Taylor's Tale helped inspire a law designed to stimulate the creation of new treatments for rare diseases and spur economic development in North Carolina.

13 Aug 2015

Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published today in Cancer Research.

13 Aug 2015

ImmunoCellular signs agreement with FDA for phase 3 registrational trial of cancer immunotherapy ICT-107

ImmunoCellular Therapeutics, Ltd. announced today that it has reached agreement with the US Food and Drug Administration on a Special Protocol Assessment (SPA) for the phase 3 registrational trial of its cancer immunotherapy ICT-107 to treat patients with newly diagnosed glioblastoma.

13 Aug 2015

IVF may be less successful if donor eggs are frozen

Women who undergo in vitro fertilization (IVF) may be less likely to reach the stage of giving birth if the donor eggs used for the procedure are frozen rather than fresh, according to a new study published in the Journal of the American Medical Association.

13 Aug 2015

Proxsys Rx provides end-to-end solution to help hospitals comply with all 340B program

Proxsys Rx, the nation's largest Integrated Outpatient Pharmacy Provider (IOPP), now provides an end-to-end solution to hospitals to help them comply with all aspects of the 340B program. Under the federally mandated 340B program, drug makers must provide eligible organizations with certain prescription drugs at significantly reduced prices.

13 Aug 2015

Inhibikase Therapeutics launches observational clinical study in patients who survived PML

Inhibikase Therapeutics, Inc. announces the launch of an observational clinical study in patients who contracted Progressive Multifocal Leukoencephalopathy (PML), the rare and often fatal brain infection that arises as an unintended side effect of some medications used for treatment of Multiple Sclerosis, Crohn's disease, Ulcerative Colitis and certain cancers of the blood and lymph.

13 Aug 2015

Dipexium reports net loss of $4.0 million for second quarter 2015

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 0.8%), a novel, broad-spectrum, topical antibiotic peptide, today reported financial results for the quarter ended June 30, 2015.

13 Aug 2015

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.

13 Aug 2015

USciences professor provides infection control measures for college-bound students

Thousands of students across Greater Philadelphia will soon start the next chapter of their lives as they begin their college journeys away from home.

13 Aug 2015

ADDF establishes Goodes Prize to recognize scientists in Alzheimer's drug discovery research

Thanks to the generosity of former Warner-Lambert CEO and Chairman Melvin R. Goodes and his family, the Alzheimer's Drug Discovery Foundation has established the only prize specifically recognizing scientists in Alzheimer's drug discovery research. Mr. Goodes—who has been open about his own Alzheimer's diagnosis—is an honorary member of the ADDF's Board of Governors.

13 Aug 2015

New article highlights benefits and risks of cesarean delivery on maternal request

More and more mothers facing childbirth are asking for a cesarean. There are many reasons for this, ranging from the social and cultural to the personal, such as fear about the birth. A review article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztbl 112: 489-95) by two Munich gynecologists, Ioannis Mylonas and Klaus Friese, considers the risks and benefits of cesarean delivery on maternal request.

13 Aug 2015

Swarm intelligence can help to improve breast cancer screening

Breast cancer is the most frequent type of cancer in women and currently accounts for 29% of all new cancer cases in the U.S. Wide-ranging mammography screening programs have been set up for early diagnosis. However, even if two physicians assess the x-rays, which is the usual procedure in Europe, this often leads to wrong decisions: about 20% of patients with cancer are diagnosed as being cancer-free, whereas about 20% of cancer-free patients are diagnosed with cancer.

13 Aug 2015

Medical News

Merck, MD Anderson form strategic clinical research collaboration to evaluate anti-PD-1 therapy

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Nutrastar's net revenue increases 1.8% to $13.24 million in second quarter 2015

Rhythm Metabolic completes $40 million Series A financing

Health Gorilla announces launch of expanded physician portal

CPhI reports positive outlook on the Chinese pharmaceutical market

New endoscopic system differentiates between malignant and benign tumors in gastrointestinal tract

RealTime Dynamix: New monthly service launched for pharmaceutical markets

Charlotte charity Taylor's Tale inspires new law to create treatments for rare diseases, spur growth in NC

Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

ImmunoCellular signs agreement with FDA for phase 3 registrational trial of cancer immunotherapy ICT-107

IVF may be less successful if donor eggs are frozen

Proxsys Rx provides end-to-end solution to help hospitals comply with all 340B program

Inhibikase Therapeutics launches observational clinical study in patients who survived PML

Dipexium reports net loss of $4.0 million for second quarter 2015

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

USciences professor provides infection control measures for college-bound students

ADDF establishes Goodes Prize to recognize scientists in Alzheimer's drug discovery research

New article highlights benefits and risks of cesarean delivery on maternal request

Swarm intelligence can help to improve breast cancer screening

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News